PRECIPIO, INC. Deferred Tax Liabilities, Gross
PRECIPIO, INC. (PRPO) had Deferred Tax Liabilities, Gross of $2.47 million as of 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net
us-gaap:DeferredIncomeTaxLiabilities · last filed 2026-03-30
- 2025-12-31: Deferred Tax Liabilities, Gross $2.47M.
- 2024-12-31: Deferred Tax Liabilities, Gross $1.91M.
- 2023-12-31: Deferred Tax Liabilities, Gross $1.89M.
- 2022-12-31: Deferred Tax Liabilities, Gross $2.26M.
| Period end | Deferred Tax Liabilities, Gross | Deferred Tax Liabilities, Gross as first filed |
|---|---|---|
| 2025-12-31 | $2.47M 10-K · filed 2026-03-30 | |
| 2024-12-31 | $1.91M 10-K · filed 2026-03-30 | |
| 2023-12-31 | $1.89M 10-K · filed 2025-03-27 | |
| 2022-12-31 | $2.26M 10-K · filed 2024-03-29 | |
| 2021-12-31 | $3.86M 10-K · filed 2023-03-30 | |
| 2020-12-31 | $3.94M 10-K · filed 2022-03-30 | |
| 2019-12-31 | $4.24M 10-K · filed 2021-03-29 | |
| 2018-12-31 | $2.11M 10-K · filed 2020-03-27 | |
| 2017-12-31 | $2.19M 10-K · filed 2019-04-16 | $4.53M 10-K · filed 2018-04-13 |
| 2016-12-31 | $16.00K 10-K · filed 2018-04-13 | $0.00 10-K · filed 2017-04-13 |
| 2015-12-31 | $50.00K 10-K · filed 2017-04-13 | |
| 2014-12-31 | $102.00K 10-K · filed 2016-04-14 | $719.00K 10-K · filed 2015-04-15 |
| 2013-12-31 | $211.00K 10-K · filed 2015-04-15 | |
| 2012-12-31 | $698.00K 10-K · filed 2014-03-27 | $19.00K 10-K · filed 2013-03-14 |
| 2011-12-31 | $2.00K 10-K · filed 2013-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |